<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Exp Med</journal-id>
      <journal-title>The Journal of Experimental Medicine</journal-title>
      <issn pub-type="ppub">0022-1007</issn>
      <issn pub-type="epub">1540-9538</issn>
      <publisher>
        <publisher-name>The Rockefeller University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">9419212</article-id>
      <article-id pub-id-type="pmc">2199185</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in the Human <italic>&#x3BB;5/14.1</italic> Gene Result in B Cell Deficiency and Agammaglobulinemia </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Minegishi</surname>
            <given-names>Yoshiyuki</given-names>
          </name>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coustan-Smith</surname>
            <given-names>Elaine</given-names>
          </name>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Yui-Hsi</given-names>
          </name>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cooper</surname>
            <given-names>Max D.</given-names>
          </name>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campana</surname>
            <given-names>Dario</given-names>
          </name>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">*</xref>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Conley</surname>
            <given-names>Mary Ellen</given-names>
          </name>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">*</xref>
          <xref ref-type="aff" rid="N0x1ab0d30N0x3bafb18">&#xA7;</xref>
        </contrib>
      </contrib-group>
      <aff id="N0x1ab0d30N0x3bafb18">From the <label>*</label>Departments of Immunology and Hematology/Oncology, St. Jude Children's Research  Hospital, Memphis, Tennesse 38105; <label>&#x2021;</label>Departments of Pediatrics and Microbiology, Howard Hughes  Medical Institute, Birmingham, Alabama 35294; and <label>&#xA7;</label>Department of Pediatrics, University of  Tennessee, Memphis, Tennessee 38105</aff>
      <author-notes>
        <fn>
          <p>Address correspondence to Mary Ellen Conley, Department of Immunology, St. Jude Children's Research  Hospital, 332 N. Lauderdale, Memphis, TN 38105. Phone: 901-495-3512; Fax: 901-495-3107; E-mail:  <email>maryellen.conley@stjude.org</email></p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>5</day>
        <month>1</month>
        <year>1998</year>
      </pub-date>
      <volume>187</volume>
      <issue>1</issue>
      <fpage>71</fpage>
      <lpage>77</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>7</month>
          <year>1997</year>
        </date>
        <date date-type="rev-recd">
          <day>27</day>
          <month>10</month>
          <year>1997</year>
        </date>
      </history>
      <copyright-year>1998</copyright-year>
      <abstract>
        <p>B cell precursors transiently express a pre&#x2013;B cell receptor complex consisting of a rearranged  mu heavy chain, a surrogate light chain composed of &#x3BB;5/14.1 and VpreB, and the immunoglobulin  (Ig)-associated signal transducing chains, Ig&#x3B1; and Ig&#x3B2;. Mutations in the mu heavy chain are associated with a complete failure of B cell development in both humans and mice, whereas mutations in murine &#x3BB;5 result in a leaky phenotype with detectable humoral responses. In evaluating patients with agammaglobulinemia and markedly reduced numbers of B cells, we identified  a boy with mutations on both alleles of the gene for <italic>&#x3BB;</italic>5/<italic>14.1.</italic> The maternal allele carried a premature stop codon in the first exon of <italic>&#x3BB;</italic>5/<italic>14.1</italic> and the paternal allele demonstrated three basepair substitutions in a 33-basepair sequence in exon 3. The three substitutions correspond to  the sequence in the <italic>&#x3BB;</italic>5/<italic>14.1</italic> pseudogene <italic>16.1</italic> and result in an amino acid substitution at an invariant proline. When expressed in COS cells, the allele carrying the pseudogene sequence resulted in defective folding and secretion of mutant &#x3BB;5/14.1. These findings indicate that expression of the functional &#x3BB;5/14.1 is critical for B cell development in the human.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Early B cell development is dependent on the orchestrated control of sequential immunoglobulin gene rearrangements and selective expansion of cells that have  successfully passed checkpoint controls that evaluate rearrangements (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). The pre&#x2013;B cell receptor, which consists  of the membrane form of a rearranged mu heavy chain, a  surrogate light chain composed of VpreB and &#x3BB;5/14.1, and  the immunoglobulin-associated signal transducing chains,  Ig&#x3B1; and Ig&#x3B2;, play a pivotal role in this process (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Failure to express the membrane form of mu heavy chain in  both humans and mice results in a complete block in B cell  differentiation (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>). In the mouse, experimentally introduced defects in &#x3BB;5 cause a block in B cell development at  the transition between the pro&#x2013;B cell and the pre&#x2013;B cell  stage (<xref ref-type="bibr" rid="B8">8</xref>). However, the block is not absolute, and by 4 mo  of age, affected mice have &#x223C;20% of the normal number of  B cells and they are able to make antibodies to both T cell&#x2013; dependent and &#x2013;independent antigens (<xref ref-type="bibr" rid="B8">8</xref>). The effects of  mutations in VpreB have not been evaluated in the mouse,  perhaps because there are at least two genes for <italic>VpreB</italic> (<xref ref-type="bibr" rid="B9">9</xref>),  both of which are transcribed and expressed in early B cell  development (<xref ref-type="bibr" rid="B10">10</xref>).</p>
    <p>The genes for the surrogate light chains are expressed exclusively in pro&#x2013;B cells and pre&#x2013;B cells (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B11">11</xref>), and can act  as markers for these stages of differentiation. The proteins  encoded by these genes can escort the mu chain to the cell  surface (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>), and they may assess the ability of the rearranged mu chain to bind effectively to light chains (<xref ref-type="bibr" rid="B13">13</xref>).  Whether the surrogate light chain combines with the mu  chain to form an extracellular ligand-binding motif is less  clear (<xref ref-type="bibr" rid="B13">13</xref>). The NH<sub>2</sub>-terminal portion of VpreB has high  homology to the variable region (<xref ref-type="bibr" rid="B9">9</xref>), and the COOH-terminal portion of &#x3BB;5/14.1 has homology to J region and  lambda constant regions (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B14">14</xref>). VpreB and &#x3BB;5/14.1 are  noncovalently linked to one another (<xref ref-type="bibr" rid="B15">15</xref>), and, &#x3BB;5/14.1 is  covalently linked to the mu chain via a COOH-terminal  cysteine (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>).</p>
    <p>The organization of the surrogate light chain genes is  somewhat different in the human compared to the mouse.  In the human, only a single <italic>VpreB</italic> gene has been reported;  however, there are three <italic>&#x3BB;5</italic>-like genes that have been  named based on their size in EcoRI-digested genomic DNA  (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B17">17</xref>). The functional <italic>&#x3BB;5</italic>-like gene is on a 14-kb EcoRI  fragment. There are also two <italic>&#x3BB;5</italic>-like pseudogenes, <italic>16.1</italic>  and <italic>16.2</italic> (also called <italic>F&#x3BB;</italic>-<italic>1</italic> [17,18]), that have over 95% homology to <italic>&#x3BB;5/14.1</italic> in exons 2 and 3, but lack exon 1 and  associated regulatory elements (<xref ref-type="bibr" rid="B17">17</xref>). In addition, there are 7  to 10 lambda constant region genes, the most 5&#x2032; of which  has high homology to <italic>&#x3BB;5/14.1.</italic> It has been postulated that  this gene, <italic>G&#x3BB;1</italic>, may be expressed in an unrearranged form  like <italic>&#x3BB;5/14.1</italic> (<xref ref-type="bibr" rid="B19">19</xref>). Within the human lambda light chain  locus on chromosome 22q11.22, the gene for <italic>VpreB</italic> is  within the lambda variable region cluster of genes (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>),  whereas the genes for <italic>&#x3BB;5/14.1</italic> and <italic>16.2</italic> are 800&#x2013;1,000 kb  distal to the lambda constant region genes. The pseudogene  <italic>16.1</italic> is 1,500 kb distal or telomeric to <italic>&#x3BB;5/14.1</italic> (<xref ref-type="bibr" rid="B21">21</xref>).</p>
    <p>In humans, mutations in Bruton's tyrosine kinase (Btk)<sup>1</sup>,  a cytoplasmic tyrosine kinase that is defective in X-linked  agammaglobulinemia (XLA; references <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>), as well as  mutations in mu heavy chain (<xref ref-type="bibr" rid="B5">5</xref>), result in a block in B cell  maturation that is first manifest at the transition from the  pro&#x2013;B cell to pre&#x2013;B cell stage of differentiation (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>).  However, mutations in these two genes do not account for  all of the patients with isolated defects in B cell development (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>); therefore, we examined the possibility  that some patients might have mutations in other components of the pre&#x2013;B cell receptor complex.</p>
    <sec id="MaterialsMethods" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec disp-level="3">
        <title>Patients.</title>
        <p>DNA from eight unrelated patients with sporadic  agammaglobulinemia was screened for mutations in <italic>&#x3BB;5/14.1</italic>,  <italic>VpreB</italic>, <italic>Ig&#x3B1;</italic>, and <italic>Ig&#x3B2;</italic>. The patient with mutations in &#x3BB;5/14.1 had  the onset of recurrent otitis at 2 mo of age and was recognized to  have hypogammaglobulinemia and absent B cells at 3 yr of age  when he developed hemophilus meningitis complicated by arthritis. At that time he was seronegative for the T cell&#x2013;dependent  antigens tetanus toxoid, diphtheria toxoid, and conjugated hemophilus influenza, despite previous immunization. He also failed to  make antibody to the T cell&#x2013;independent antigens in blood group  substances. On four evaluations since that time, the patient has  never had detectable CD19<sup>+</sup> B cells by routine clinical testing. At  5 yr of age, while receiving gammaglobulin replacement therapy,  he had no measurable serum IgM and IgA (&lt;8 mg/dl). He had  normal numbers of T cells and normal proliferative responses to  mitogens.</p>
      </sec>
      <sec disp-level="3">
        <title>Mutation Detection.</title>
        <p>Genomic DNA was analyzed by single-strand conformation polymorphism (SSCP; reference <xref ref-type="bibr" rid="B26">26</xref>) using  the following primers to amplify <italic>&#x3BB;5/14.1</italic>: exon 1, 5&#x2032;-ACCAGGGCACCACTCTCTA-3&#x2032; and 5&#x2032;-GTCATCCTTTCCCGCCTCT-3&#x2032;; exon 2, 5&#x2032;-TGGGTCACAGCCTACACACT-3&#x2032; and 5&#x2032;-CAGAAGAGGGTGGGACAGC-3&#x2032;; exon 3,  5&#x2032;-TCTCACCCCCTCCTCTGTCC-3&#x2032; and 5&#x2032;-TGCAGAGAGAGAGACCCTTCC-3&#x2032;. PCR conditions were 5 min at  95&#xB0;C followed by 30 cycles of 95&#xB0;C for 45 s, 62&#xB0;C for 30 s, and  72&#xB0;C for 30 s with a final extension of 5 min at 72&#xB0;C. Before  electrophoresis, PCR products from exons 1 and 3 were digested  with PvuII and BstUI, respectively. BstUI would be expected to  cleave the functional <italic>&#x3BB;5/14.1</italic> exon 3 but not exon 3 from the  pseudogenes. Sequences demonstrating altered mobility in SSCP  were cloned into TA vector (Invitrogen, Carlsbad, CA) and sequenced using M13 primers. The mutations were confirmed using a second independent PCR reaction.</p>
      </sec>
      <sec disp-level="3">
        <title>Analysis of &#x3BB;5/14.1 cDNA.</title>
        <p>Reverse transcriptase PCR (RT-PCR) was used to amplify <italic>&#x3BB;</italic>5/<italic>14.1</italic> cDNA from the patient's  mononuclear bone marrow cells using the primers 5&#x2032;-ACGCATGTGTTTGGCAGC-3&#x2032; and 5&#x2032;-GGCGTCAGGCTCAGGTA-3&#x2032;. The PCR products were cloned and sequenced as above.  PCR products were digested with MspI (<named-content content-type="company" xlink:href="neb">New England Biolabs</named-content>,  Beverly, MA) for 2 h at 37&#xB0;C and visualized by ethidium bromide  staining in a 1.8% agarose gel.</p>
      </sec>
      <sec disp-level="3">
        <title>Immunofluorescence Staining.</title>
        <p>Peripheral blood lymphocytes  and bone marrow cells were stained using previously described  techniques and reagents (<xref ref-type="bibr" rid="B5">5</xref>). In addition, fixed cells were stained  with an IgG1 murine monoclonal anti-VpreB antibody produced  in mice immunized with a recombinant human VpreB protein  (Wang, Y.-H., J. Nomura, O.M. Faye-Petersen, and M.D. Cooper, manuscript in preparation).</p>
      </sec>
      <sec disp-level="3">
        <title>Vector Construction.</title>
        <p>The pre&#x2013;B cell line Nalm6 was used as  the source of cDNA to amplify the genes for <italic>&#x3BB;5</italic>/<italic>14.1</italic> and <italic>VpreB</italic>  by RT-PCR. PCR primers for &#x3BB;5/14.1 were 5&#x2032;-AGGGCACCACTCTCTAGGGA-3&#x2032; and 5&#x2032;-TGCAGAGAGAGAGACCCTTCC-3&#x2032;, and for VpreB were 5&#x2032;-GGCCACAGGAGTCAGAGCT-3&#x2032; and 5&#x2032;-GATGCGTGCCTCTGCTGTCTT-3&#x2032;.  PCR products were cloned into the TA vector and the Pro  142Leu mutant was generated by replacing the endogenous SacI&#x2013; BamHI fragment of exon 3 with that of the patient. After the sequence had been verified, the three cDNA products were cloned  into the pcDNA3 expression vector (Invitrogen) that contains a  CMV promoter and SV40 origin of replication.</p>
      </sec>
      <sec disp-level="3">
        <title>Transfection and Immunoprecipitation.</title>
        <p>COS7 cells were transfected  with expression vectors for the normal or mutant &#x3BB;5/14.1, with or  without VpreB using lipofectamine (<named-content content-type="company" xlink:href="gibco">GIBCO BRL</named-content>, Gaithersburg,  MD) according to the manufacturer's protocol. The cells were metabolically labeled with 0.3 mCi of <sup>35</sup>S-Translabel (ICN, Irvine, CA)  for 2 h, 44 h after transfection. Labeled cells were lysed in 1% Triton  X-100, 10 mM Tris (pH 8.0), 140 mM NaCl, 1% bovine hemoglobin, 0.2 U/ml aprotinin, and 1 mM PMSF. After preclearing, lysates were incubated with murine anti-VpreB or goat antilambda  chain antibodies (<named-content content-type="company" xlink:href="sigma">Sigma Chemical Co.</named-content>, St. Louis, MO). Specific proteins were immunoprecipitated with protein G Sepharose (<named-content content-type="company" xlink:href="pharmacia">Pharmacia</named-content>, Uppsala, Sweden) and eluted with a sample buffer containing  50 mM Tris (pH 6.8), 10% glycerol, 1% SDS, 0.001% bromophenol blue, with or without 5% 2-mercaptoethanol. Proteins were  separated by 12.5% SDS-PAGE and detected by fluorography.</p>
      </sec>
    </sec>
    <sec id="Results">
      <title>Results</title>
      <sec disp-level="4">
        <title>Identification of Mutations in &#x3BB;5/14.1.</title>
        <p>Genomic DNA  samples from eight patients with defects in B cell development but without mutations in Btk or mu heavy chain  were screened for mutations in genes that encode components of the pre&#x2013;B cell receptor complex. PCR was used to  amplify individual exons by flanking splice sites and the  products were analyzed with SSCP. A 5-yr-old boy with  &lt;1% of the normal number of B cells and severe hypogammaglobulinemia was found to have alterations in exons 1  and 3 of the surrogate light chain gene, <italic>&#x3BB;5/14.1.</italic> Although  both the patient's mother and father had normal percentages of circulating CD19<sup>+</sup> B cells, 6 and 10% respectively,  SSCP analysis of genomic DNA from the patient's parents  indicated that the abnormality in exon 1 was derived from  the maternal allele and the abnormality in exon 3 was derived from the paternal allele. Both exons were cloned and  sequenced.</p>
        <p>The patient's exon 1 sequence revealed a C to T transition at codon 22, resulting in the substitution of a premature stop codon for the wild-type glutamine (Fig. <xref ref-type="fig" rid="F1">1</xref>). In  exon 3, there were three basepair substitutions: T to C at nucleotide 393 (codon 131), T to C at nucleotide 420 (codon  140), and C to T at nucleotide 425 (codon 142). The first  two substitutions do not change the coding sequence; however, the third results in the replacement of the wild-type  proline with leucine. The proline at this site, which occurs  in the loop linking the second and third strands of one of  the two beta pleated sheets that compose the immunoglobulin domain (<xref ref-type="bibr" rid="B33">33</xref>), is conserved not only in lambda constant  region domains in all species evaluated, but also in most  immunoglobulin domains (<xref ref-type="bibr" rid="B11">11</xref>). SSCP analysis of exon 3 of  <italic>&#x3BB;5/14.1</italic> in DNA from 100 individuals did not demonstrate  the pattern seen in the patient's paternal allele in any other  samples. </p>
        <p>The three basepair substitutions in the paternal allele of  <italic>&#x3BB;5/14.1</italic> are the same as those found at the corresponding  site in exon 3 of the <italic>&#x3BB;5/14.1</italic> pseudogene, <italic>16.1</italic> (17; Fig.  <xref ref-type="fig" rid="F1">1</xref>). To determine whether the altered sequence could be  attributed to gross rearrangements within the lambda locus,  DNA from the patient was digested with EcoRI and HindIII and examined by Southern blot using an exon 3 <italic>&#x3BB;5/ 14.1</italic> probe. The results demonstrated the expected fragments representing the &#x3BB;5-like genes and the lambda constant region genes, and did not reveal any altered fragments  (Fig. <xref ref-type="fig" rid="F2">2</xref>). </p>
        <p>The mutation in the paternal allele was confirmed by analyzing cDNA from the patient's bone marrow. RT-PCR,  using primers from within exons 2 and 3, allowed the amplification of the 3&#x2032; portion of the patient's <italic>&#x3BB;5/14.1</italic> gene.  The C to T basepair substitution at nucleotide 425 would  be expected to destroy an MspI site at this locus. To determine the proportion of the transcripts derived from the  maternal and paternal alleles, the RT-PCR products from a  control and the patient were digested with MspI and examined in an agarose gel. Although all of the product from the  normal control was digested, none of the product from the  patient was cleaved, indicating that all of the transcripts were  derived from the paternal allele (Fig. <xref ref-type="fig" rid="F3">3</xref>). The patient's PCR  product was sequenced and revealed the three basepair substitutions specific to the <italic>16.1</italic> pseudogene sequence flanked  by sequence characteristic of the functional <italic>&#x3BB;5/14.1</italic> gene  (Fig. <xref ref-type="fig" rid="F1">1</xref>). These results provide strong support for the occurrence of a gene conversion event in the lambda locus. </p>
      </sec>
      <sec disp-level="4">
        <title>In Vivo Consequences of Mutations in &#x3BB;5/14.1.</title>
        <p>The effects of the <italic>&#x3BB;5/14.1</italic> gene mutations on B cell development  were examined in the patient's peripheral blood and bone  marrow. In normal individuals, between 5 and 18% of the  peripheral blood lymphocytes are B cells as defined by expression of CD19. Our past studies have shown that in patients with X-linked agammaglobulinemia, who have mutations in Btk, B cells represent between 0.01 and 0.10% of  lymphocytes (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>), whereas in patients with mutations  in mu heavy chain, B cells cannot be detected (<xref ref-type="bibr" rid="B5">5</xref>). In the  patient with mutations in &#x3BB;5/14.1, 0.06% of the peripheral  blood lymphocytes expressed CD19. Like normal circulating B cells, these cells had low intensity expression of surface IgM and dim expression of CD38. By contrast, B cells  seen in patients with mutations in Btk expressed an immature phenotype as defined by high intensity expression of  both surface IgM and CD38 (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>).</p>
        <p>Bone marrow cells from the patient and a normal age-matched control were stained in suspension with antibodies  to surface immunoglobulin and CD19. Although a small  number of CD19<sup>+</sup> cells could be detected, there were almost no mature B cells as defined by coexpression of CD19  and surface immunoglobulin (Fig. <xref ref-type="fig" rid="F4">4</xref> <italic>A</italic>). Over 85% of the  CD19<sup>+</sup> cells were positive for CD34 (Fig. <xref ref-type="fig" rid="F4">4</xref> <italic>B</italic>), indicating  a block at the transition between the pro&#x2013;B cell and pre&#x2013;B  cell stage of differentiation. This block was also seen in permeabilized cells stained for terminal deoxynucleotidyl  transferase (TdT) and surface or cytoplasmic IgM (Fig. <xref ref-type="fig" rid="F4">4</xref>  <italic>C</italic>). Although the number of TdT<sup>+</sup> cells in the patient was  comparable to the control, there were very few cells at the  next stage of differentiation, cells which express cytoplasmic  mu heavy chain. Bone marrow from &#x3BB;5 knockout mice has  markedly decreased expression of VpreB (<xref ref-type="bibr" rid="B36">36</xref>), suggesting  that in the absence of &#x3BB;5, VpreB is unstable. In bone marrow of controls, a mean of 82% of TdT<sup>+</sup> cells was dimly  positive for cytoplasmic VpreB, whereas, in the patient,  14% of the TdT<sup>+</sup> cells were VpreB<sup>+</sup>. </p>
      </sec>
      <sec disp-level="4">
        <title>Functional Consequences of Mutations in &#x3BB;5/14.1.</title>
        <p>To determine the functional consequences of the amino acid  substitution in exon 3 of <italic>&#x3BB;5/14.1</italic>, expression vectors for  VpreB and the normal and mutant <italic>&#x3BB;5</italic>/14.1 genes were introduced into COS7 cells by lipofection. In metabolically  labeled cells transfected with <italic>VpreB</italic> and the normal or mutant <italic>&#x3BB;5/14.1</italic>, both <italic>VpreB</italic> and <italic>&#x3BB;5/14.1</italic> could be immunoprecipitated from cell lysates using a monoclonal anti-VpreB antibody, demonstrating that the mutant as well as  the normal &#x3BB;5/14.1 could bind to VpreB. However, analysis of supernatants from cells transfected with the same vectors indicated that normal &#x3BB;5/14.1 was secreted into the supernatant with VpreB, as previously described (<xref ref-type="bibr" rid="B13">13</xref>); whereas  the mutant &#x3BB;5/14.1 was not secreted (Fig. <xref ref-type="fig" rid="F5">5</xref> <italic>A</italic>). </p>
        <p>Because appropriate protein folding is required for protein secretion, and the amino acid substitution in the mutant &#x3BB;5/14.1 was at a site that would be expected to influence tertiary structure, the capacity of the normal and  mutant &#x3BB;5/14.1 proteins to fold was compared in reducing  and nonreducing conditions. As shown in Fig. <xref ref-type="fig" rid="F5">5</xref> <italic>B</italic>, under  nonreducing conditions, &#x223C;50% of the normal &#x3BB;5/14.1  moved through the gel more rapidly because of protein  folding, but none of the mutant &#x3BB;5/14.1 demonstrated altered migration. When coupled with the decreased expression of VpreB in the patient's bone marrow, these studies  suggest that the mutant &#x3BB;5/14.1 was improperly folded and  degraded within the endoplasmic reticulum (<xref ref-type="bibr" rid="B37">37</xref>).</p>
      </sec>
    </sec>
    <sec id="Discussion">
      <title>Discussion</title>
      <p>The results of these studies demonstrate that mutations in  &#x3BB;5/14.1 can result in profound B cell deficiency in humans. Transcription of the <italic>&#x3BB;5/14.1</italic> pseudogenes, <italic>16.2</italic> and  <italic>G&#x3BB;</italic>1, has been described (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>), but it is not clear  whether these transcripts are needed for normal development. The severe block in B cell differentiation in our patient indicates that the surrogate light chain pseudogenes in  the patient could not compensate for the mutations in the  <italic>&#x3BB;5/14.1</italic> gene. The fact that the patient had two different  mutations in &#x3BB;5/14.1 and that he was not a member of an  isolated or inbred population, suggests that there may be  other similar patients.</p>
      <p>The mutation derived from the maternal allele in the patient was a C to T transition in the first exon resulting in  the replacement of a wild-type glutamine with a premature  stop codon. Premature stop codons in many genes, including Btk, &#x3B2; globin, and dihydrofolate reductase, are associated with faulty processing of the pre&#x2013;messenger RNA and  poor accumulation of the transcript in the cytoplasm (<xref ref-type="bibr" rid="B26">26</xref>,  <xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>), as was seen in this case. Thus, this mutation is  functionally a null mutation.</p>
      <p>The mutation in the paternal allele most likely occurred  by gene conversion rather than by two unequal crossover  events or three separate basepair substitutions. None of the  three basepair substitutions seen in the patient's paternal allele were found individually in 100 normal people. Gene  conversion is an uncommon mechanism of mutation; however, it has been suggested that gene conversion between  the two highly homologous human fetal globin genes, <italic>A&#x3B3;</italic>  and <italic>G&#x3B3;</italic>, explains the genetic variation within these tandemly duplicated genes (<xref ref-type="bibr" rid="B40">40</xref>). Immediate proximity of the  donor and recipient DNA does not appear to be necessary  for gene conversion. Although the functional von Willebrand factor gene is on chromosome 12, a portion of the  gene is duplicated as a pseudogene on chromosome 22. In  two families with von Willebrand disease, two different segments of the functional gene were replaced by portions of  the pseudogene resulting in three basepair substitutions  (<xref ref-type="bibr" rid="B41">41</xref>), as in our patient. The fact that gene conversion is used  to generate antibody diversity in some species (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>) suggests that immunoglobulin domains may be unusually susceptible to this type of mutational event.</p>
      <p>It is intriguing that the defects in &#x3BB;5/14.1 seen in the patient described in this paper resulted in a disease more severe than that seen in mice lacking &#x3BB;5 due to homologous  recombination. One could postulate that the mutant &#x3BB;5/ 14.1 protein produced in the patient's bone marrow might  have a more deleterious effect than the absence of &#x3BB;5 in the  knockout mice. However, based on the observation that  the patient's father, who was heterozygous for this mutation, had normal B cell numbers, the possibility of a dominant negative mutation is unlikely. The immune function  in the &#x3BB;5 knockout mice improved with time (<xref ref-type="bibr" rid="B8">8</xref>); it is possible that older patients with defects in &#x3BB;5/14.1 may repair  their B cell defects and antibody-forming capacity. Other  explanations can be considered. The leaky phenotype in  &#x3BB;5-deficient mice has been attributed to B cell precursors  in which light chain gene rearrangement preceded heavy  chain gene rearrangement, thus negating the requirement  for &#x3BB;5 expression (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Although studies using human  EBV-transformed B cell lines first suggested that rearrangement of light chain genes could occur before that of the  heavy chain genes (<xref ref-type="bibr" rid="B45">45</xref>), the frequency or efficiency of this  event may differ in the two species. There may be other  factors that compensate for the lack of expression of &#x3BB;5,  and these factors may differ in the human compared to the  mouse. Finally, the recovery of &#x3BB;5-deficient mice is dependent on the expansion of early B cell precursors that have  successfully rearranged both heavy and light chain genes.  There may be differences in the regulation of this expansion in the human compared to the mouse.</p>
      <p>Early B cell development in the mouse, but not the human, is highly dependent on signaling through the IL-7R  (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). By contrast, defects in Btk disrupt the pro&#x2013;B cell  to pre&#x2013;B cell transition in the human, but not in the mouse  (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Our studies demonstrating the greater consequences of mutations in &#x3BB;5/14.1 in the human compared  to the mouse further emphasize the use of studying multiple models of B cell development. Comparison of the effects of mutations in the same gene in different species  highlights the aspects of B cell signaling that are invariant  and those that may be influenced by other genetic or environmental factors.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="display-objects">
      <title>Figures and Tables</title>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Comparison of the normal and mutant <italic>&#x3BB;5/14.1</italic> genes. (<italic>A</italic>)  Partial DNA sequence of the first (<italic>left</italic>) and third (<italic>right</italic>) exon of <italic>&#x3BB;5/14.1</italic> in  the patient and in a normal control. The basepair substitutions are indicated by an asterisk. (<italic>B</italic>) Sequence alignment of the third exon of the  functional <italic>&#x3BB;5/14.1</italic> gene, the patient's <italic>&#x3BB;5/14.1</italic> gene, and the <italic>16.1</italic>  pseudogene. Only the basepairs at which <italic>&#x3BB;5/14.1</italic> and the pseudogene  <italic>16.1</italic> differ are indicated. The basepairs at which the patient's <italic>&#x3BB;5/14.1</italic>  gene correspond to the <italic>16.1</italic> gene are shown in bold type.</p>
        </caption>
        <graphic xlink:href="JEM.971258f1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Southern blot analysis of the lambda and lambda-like genes.  Genomic DNA from the patient (lane <italic>1</italic>) and four controls (lanes <italic>2&#x2013;5</italic>)  was digested with EcoRI (<italic>A</italic>) or HindIII (<italic>B</italic>) and analyzed with a probe  from the third exon of <italic>&#x3BB;5/14.1.</italic> The molecular size standards are shown  at the right side of the figure. In the EcoRI digest, the genes for <italic>&#x3BB;</italic>5/<italic>14.1</italic>  and the pseudogene <italic>16.1</italic> are indicated at the left side of the figure. The  bands at 8, 18, and 23 kb in the EcoRI digest represent previously reported polymorphic variants in the number of lambda constant region  genes (<xref ref-type="bibr" rid="B49">49</xref>).</p>
        </caption>
        <graphic xlink:href="JEM.971258f2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Analysis of <italic>&#x3BB;5/14.1</italic> cDNA from the patient's bone marrow.  RT-PCR was used to amplify the 3&#x2032; portion of the <italic>&#x3BB;5/14.1</italic> transcripts  from an age-matched control (lane <italic>1</italic>), the patient (lane <italic>2</italic>), or a negative  control (lane <italic>3</italic>). Molecular size standards (lane <italic>M</italic>), the undigested PCR  products (<italic>A</italic>), and the MspI-digested products (<italic>B</italic>) were separated by electrophoresis. All of the 266-basepair product from the control, but none  from the patient, was digested to yield 143- and 123-basepair fragments.</p>
        </caption>
        <graphic xlink:href="JEM.971258f3"/>
      </fig>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>Flow cytometric analysis of bone marrow B cell precursors  from a normal age-matched control (<italic>left</italic>) and the patient with mutations  in &#x3BB;5/14.1 (<italic>right</italic>). (<italic>A</italic>) Isometric contour plots of lymphoid-gated cells  stained with antibodies to CD19 and surface immunoglobulin (kappa +  lambda light chains). In the control, 46% of cells were CD19<sup>+</sup>, of which  29% were surface Ig (sIg)<sup>+</sup>. In the patient, 6% of cells were CD19<sup>+</sup>, with  only 0.7% of which were sIg<sup>+</sup>. (<italic>B</italic>) Three-color immunofluorescence was  used to stain cells for CD19, CD34, and sIg and CD19<sup>+</sup> cells were analyzed. In the control sample, 11% of CD19<sup>+</sup> cells were CD34<sup>+</sup> and 60%  were CD34<sup>&#x2212;</sup>, sIg<sup>&#x2212;</sup>. In the patient, 87% of CD19<sup>+</sup> cells were CD34<sup>+</sup>. (<italic>C</italic>)  Permeabilized cells were stained for TdT and surface or cytoplasmic IgM.  In the control, 5% of cells were TdT<sup>+</sup>, IgM<sup>&#x2212;</sup>, 1% were TdT<sup>+</sup>, IgM<sup>+</sup>, and  40% were TdT<sup>&#x2212;</sup>, IgM<sup>+</sup>. In the patient, 5% of cells were TdT<sup>+</sup>, IgM<sup>&#x2212;</sup>,  0.2% were TdT<sup>+</sup>, IgM<sup>+</sup>, and 0.4% were TdT<sup>&#x2212;</sup>, IgM<sup>+</sup>.</p>
        </caption>
        <graphic xlink:href="JEM.971258f4"/>
      </fig>
      <fig position="float" id="F5">
        <label>Figure 5</label>
        <caption>
          <p>Transfection of  COS7 cells with expression vectors for normal or mutant &#x3BB;5/ 14.1 and normal VpreB. (<italic>A</italic>)  Cells were transfected with <italic>VpreB</italic>  and normal <italic>&#x3BB;5/14.1</italic> (lane <italic>1</italic>),  <italic>VpreB</italic> and mutant <italic>&#x3BB;5/14.1</italic> (lane  <italic>2</italic>), <italic>VpreB</italic> alone (lane <italic>3</italic>), or an  empty vector (lane <italic>4</italic>). After  metabolic labeling, both lysates  and supernatants were immunoprecipitated with antibody to  VpreB. (<italic>B</italic>) COS7 cells were transfected with normal <italic>&#x3BB;5/14.1</italic> (lane  <italic>1</italic>), mutant <italic>&#x3BB;5/14.1</italic> (lane <italic>2</italic>), or  an empty vector (lane <italic>3</italic>), immunoprecipitated using a polyclonal  antilambda antibody, and electrophoresed under reducing (<italic>R</italic>)  or nonreducing (<italic>NR</italic>) conditions.</p>
        </caption>
        <graphic xlink:href="JEM.971258f5"/>
      </fig>
    </sec>
    <ack>
      <p>These studies were supported by grants from the National Institutes of Health AI25129, National Cancer Institute grant P30 CA21765, the Assisi Foundation, March of Dimes FY97-0384, American Lebanese Syrian  Associated Charities, and by funds from the Federal Express Chair of Excellence. M.D. Cooper is a Howard  Hughes Medical Institute Investigator.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spanopoulou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Roman</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Corcoran</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Schlissel</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Nemazee</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nussenzweig</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Shinton</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Baltimore</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1&#x2013;deficient mice</article-title>
          <source>Genes Dev</source>
          <year>1994</year>
          <volume>8</volume>
          <fpage>1030</fpage>
          <lpage>1042</lpage>
          <pub-id pub-id-type="pmid">7926785</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ardman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shinkai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lansford</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Blackwell</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Mendelsohn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rolink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Melchers</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Alt</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation</article-title>
          <source>Genes Dev</source>
          <year>1994</year>
          <volume>8</volume>
          <fpage>1043</fpage>
          <lpage>1057</lpage>
          <pub-id pub-id-type="pmid">7926786</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajewsky</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Clonal selection and learning in the antibody system</article-title>
          <source>Nature</source>
          <year>1996</year>
          <volume>381</volume>
          <fpage>751</fpage>
          <lpage>758</lpage>
          <pub-id pub-id-type="pmid">8657279</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burrows</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>B cell development and differentiation</article-title>
          <source>Curr Opin Immunol</source>
          <year>1997</year>
          <volume>9</volume>
          <fpage>239</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="pmid">9099791</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yel</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Minegishi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Coustan-Smith</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buckley</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Trubel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pachman</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Kitchingman</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Campana</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rohrer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Conley</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the mu heavy chain gene in patients with agammaglobulinemia</article-title>
          <source>N Engl J  Med</source>
          <year>1996</year>
          <volume>335</volume>
          <fpage>1486</fpage>
          <lpage>1493</lpage>
          <pub-id pub-id-type="pmid">8890099</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitamura</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rajewsky</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A B cell&#x2013;deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene</article-title>
          <source>Nature</source>
          <year>1991</year>
          <volume>350</volume>
          <fpage>423</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="pmid">1901381</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Trounstine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alt</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kurahara</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Loring</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Huszar</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus</article-title>
          <source>Int Immunol</source>
          <year>1993</year>
          <volume>5</volume>
          <fpage>647</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="pmid">8347558</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitamura</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schaal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Melchers</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rajewsky</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A critical role of &#x3BB;5 protein in B cell development</article-title>
          <source>Cell</source>
          <year>1992</year>
          <volume>69</volume>
          <fpage>823</fpage>
          <lpage>831</lpage>
          <pub-id pub-id-type="pmid">1591779</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kudo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Melchers</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>A second gene, VpreB in  the &#x3BB;<sub>5</sub>locus of the mouse, which appears to be selectively expressed in pre&#x2013;B lymphocytes</article-title>
          <source>EMBO (Eur Mol Biol Organ) J</source>
          <year>1987</year>
          <volume>6</volume>
          <fpage>2267</fpage>
          <lpage>2272</lpage>
          <pub-id pub-id-type="pmid">3117530</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pre&#x2013;B lymphocyte&#x2013;specific transcriptional control of the mouse VpreB gene</article-title>
          <source>Eur J Immunol</source>
          <year>1992</year>
          <volume>22</volume>
          <fpage>31</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">1730257</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakaguchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Melchers</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>&#x3BB;5, a new light-chain&#x2013; related locus selectively expressed in pre&#x2013;B lymphocytes</article-title>
          <source>Nature</source>
          <year>1986</year>
          <volume>324</volume>
          <fpage>579</fpage>
          <lpage>582</lpage>
          <pub-id pub-id-type="pmid">3024017</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lassoued</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Illges</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Benlagha</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Fate of surrogate light chains in B lineage cells</article-title>
          <source>J Exp  Med</source>
          <year>1996</year>
          <volume>183</volume>
          <fpage>421</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">8627155</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melchers</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Karasuyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Haasner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jameson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rolink</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The surrogate light chain in B-cell development</article-title>
          <source>Immunol Today</source>
          <year>1993</year>
          <volume>14</volume>
          <fpage>60</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">8166770</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dmitrovsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hieter</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Leder</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Turoczi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kirsch</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Hollis</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
          <article-title>Identification of three new Ig &#x3BB;-like genes in man</article-title>
          <source>J Exp Med</source>
          <year>1986</year>
          <volume>163</volume>
          <fpage>425</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">3003227</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kerr</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Hendershot</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Mu heavy chains can associate with a pseudo-light chain complex (&#x3C8; L) in human pre&#x2013;B cell lines</article-title>
          <source>Int Immunol</source>
          <year>1989</year>
          <volume>1</volume>
          <fpage>355</fpage>
          <lpage>361</lpage>
          <pub-id pub-id-type="pmid">2518725</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baltimore</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Formation of disulphide-linked &#x3BC;<sub>2</sub> &#x3C9;<sub>2</sub>tetramers in pre&#x2013;B cells by the 18K &#x3C9;-immunoglobulin light chain</article-title>
          <source>Nature</source>
          <year>1987</year>
          <volume>329</volume>
          <fpage>172</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="pmid">3114643</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bossy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Milili</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zucman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fougereau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schiff</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Organization and expression of the &#x3BB;-like genes that contribute to the &#x3BC;-&#x3C8; light chain complex in human pre&#x2013;B cells</article-title>
          <source>Int Immunol</source>
          <year>1991</year>
          <volume>3</volume>
          <fpage>1081</fpage>
          <lpage>1090</lpage>
          <pub-id pub-id-type="pmid">1760403</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schiff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Milili</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zucman-Rossi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Djabali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fougereau</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Composite exon structure of an unusual Ig &#x3BB;-like gene located at human 22q11 position</article-title>
          <source>Mamm Genome</source>
          <year>1996</year>
          <volume>7</volume>
          <fpage>598</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="pmid">8678981</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Hollis</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
          <article-title>Genomic structure of the human Ig&#x3BB;1 gene suggests that it may be expressed as an Ig&#x3BB;14.1-like protein or as a canonical B cell Ig&#x3BB; light chain: implications for Ig&#x3BB; gene evolution</article-title>
          <source>J Exp Med</source>
          <year>1991</year>
          <volume>173</volume>
          <fpage>305</fpage>
          <lpage>311</lpage>
          <pub-id pub-id-type="pmid">1703205</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frippiat</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Tomlinson</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Cherif</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Le Paslier</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Dunham</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lefranc</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2</article-title>
          <source>Hum  Mol Genet</source>
          <year>1995</year>
          <volume>4</volume>
          <fpage>983</fpage>
          <lpage>991</lpage>
          <pub-id pub-id-type="pmid">7655473</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bauer</surname>
              <given-names>TR</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>McDermid</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Budarf</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Van  Keuren</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Blomberg</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2</article-title>
          <source>Immunogenetics</source>
          <year>1993</year>
          <volume>38</volume>
          <fpage>387</fpage>
          <lpage>399</lpage>
          <pub-id pub-id-type="pmid">8406611</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsukada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saffran</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Rawlings</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Parolini</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Klisak</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sparkes</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Kubagawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mohandas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Quan</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia</article-title>
          <source>Cell</source>
          <year>1993</year>
          <volume>72</volume>
          <fpage>279</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="pmid">8425221</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vetrie</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vorechovsky</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sideras</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Holland</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Flinter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hammarstrom</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kinnon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Levinsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bobrow</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The gene involved in X-linked agammaglobulinemia is a member of the <italic>src</italic>family of protein-tyrosine kinases</article-title>
          <source>Nature</source>
          <year>1993</year>
          <volume>361</volume>
          <fpage>226</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">8380905</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearl</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Vogler</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Okos</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Crist</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Lawton</surname>
              <given-names>AR</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states</article-title>
          <source>J Immunol</source>
          <year>1978</year>
          <volume>120</volume>
          <fpage>1169</fpage>
          <lpage>1175</lpage>
          <pub-id pub-id-type="pmid">346998</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campana</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Farrant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Inamdar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>ADB</given-names>
            </name>
            <name>
              <surname>Janossy</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia</article-title>
          <source>J  Immunol</source>
          <year>1990</year>
          <volume>145</volume>
          <fpage>1675</fpage>
          <lpage>1680</lpage>
          <pub-id pub-id-type="pmid">2391416</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conley</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Fitch-Hilgenberg</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Cleveland</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Parolini</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Rohrer</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase</article-title>
          <source>Hum Mol Genet</source>
          <year>1994</year>
          <volume>3</volume>
          <fpage>1751</fpage>
          <lpage>1756</lpage>
          <pub-id pub-id-type="pmid">7849697</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bradley</surname>
              <given-names>LAD</given-names>
            </name>
            <name>
              <surname>Sweatman</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Lovering</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Levinsky</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Kinnon</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis</article-title>
          <source>Hum Mol Genet</source>
          <year>1994</year>
          <volume>3</volume>
          <fpage>79</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">8162056</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagemann</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia</article-title>
          <source>Hum Mol Genet</source>
          <year>1994</year>
          <volume>3</volume>
          <fpage>1743</fpage>
          <lpage>1749</lpage>
          <pub-id pub-id-type="pmid">7880320</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conley</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Sweinberg</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Females with a disorder phenotypically identical to X-linked agammaglobulinemia</article-title>
          <source>J Clin Immunol</source>
          <year>1992</year>
          <volume>12</volume>
          <fpage>139</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">1560108</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Winchester</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schulkind</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Frias</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Ayoub</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Hypoimmunoglobulinemia with normal T cell function in female siblings</article-title>
          <source>Clin Immunol Immunopathol</source>
          <year>1977</year>
          <volume>7</volume>
          <fpage>364</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="pmid">301456</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de la Morena</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haire</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Litman</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Litman</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Predominance of sterile immunoglobulin transcripts in a female phenotypically resembling Bruton's agammaglobulinemia</article-title>
          <source>Eur  J Immunol</source>
          <year>1995</year>
          <volume>25</volume>
          <fpage>809</fpage>
          <lpage>815</lpage>
          <pub-id pub-id-type="pmid">7705412</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meffre</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fougereau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Argenson</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Aubaniac</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Schiff</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Cell surface expression of surrogate light chain (&#x3C8;L) in the absence of mu on human pro&#x2013;B cell lines and normal pro&#x2013;B cells</article-title>
          <source>Eur J Immunol</source>
          <year>1996</year>
          <volume>26</volume>
          <fpage>2172</fpage>
          <lpage>2180</lpage>
          <pub-id pub-id-type="pmid">8814264</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amzel</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Poljak</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Three-dimensional structure of immunoglobulins</article-title>
          <source>Annu Rev Biochem</source>
          <year>1979</year>
          <volume>48</volume>
          <fpage>961</fpage>
          <lpage>997</lpage>
          <pub-id pub-id-type="pmid">89832</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conley</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>B cells in patients with X-linked agammaglobulinemia</article-title>
          <source>J Immunol</source>
          <year>1985</year>
          <volume>134</volume>
          <fpage>3070</fpage>
          <lpage>3074</lpage>
          <pub-id pub-id-type="pmid">3920309</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tedder</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Crain</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kubagawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Clement</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases</article-title>
          <source>J  Immunol</source>
          <year>1985</year>
          <volume>135</volume>
          <fpage>1786</fpage>
          <lpage>1791</lpage>
          <pub-id pub-id-type="pmid">3160779</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rolink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karasuyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Grawunder</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Haasner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Melchers</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>B cell development in mice  with a defective &#x3BB;<sub>5</sub>gene</article-title>
          <source>Eur J Immunol</source>
          <year>1993</year>
          <volume>23</volume>
          <fpage>1284</fpage>
          <lpage>1288</lpage>
          <pub-id pub-id-type="pmid">7684685</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knittler</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Dirks</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>IG</given-names>
            </name>
          </person-group>
          <article-title>Molecular chaperones involved in protein degradation in the endoplasmic reticulum: quantitative interaction of the heat shock cognate protein BiP with partially folded immunoglobulin light chains that are degraded in the endoplasmic reticulum</article-title>
          <source>Proc  Natl Acad Sci USA</source>
          <year>1995</year>
          <volume>92</volume>
          <fpage>1764</fpage>
          <lpage>1768</lpage>
          <pub-id pub-id-type="pmid">7878056</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baserga</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Benz</surname>
              <given-names>EJ</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>&#x3B2;-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1992</year>
          <volume>89</volume>
          <fpage>2935</fpage>
          <lpage>2939</lpage>
          <pub-id pub-id-type="pmid">1557399</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Urlaub</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Ciudad</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Chasin</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Nonsense mutations in the dihydrofolate reductase gene affect RNA processing</article-title>
          <source>Mol Cell Biol</source>
          <year>1989</year>
          <volume>9</volume>
          <fpage>2868</fpage>
          <lpage>2880</lpage>
          <pub-id pub-id-type="pmid">2779551</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Powers</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Smithies</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Short gene conversions  in the human fetal globin gene region: a by-product of chromosome pairing during meiosis? </article-title>
          <source>Genetics</source>
          <year>1986</year>
          <volume>112</volume>
          <fpage>343</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="pmid">2416635</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eikenboom</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Vink</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Briet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sixma</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Reitsma</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence</article-title>
          <source>Proc Natl  Acad Sci USA</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>2221</fpage>
          <lpage>2224</lpage>
          <pub-id pub-id-type="pmid">8134377</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reynaud</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Anquez</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Grimal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Weill</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>A hyperconversion mechanism generates the chicken light chain preimmune repertoire</article-title>
          <source>Cell</source>
          <year>1987</year>
          <volume>48</volume>
          <fpage>379</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">3100050</pub-id>
        </citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Creation of immunoglobulin diversity by intrachromosomal gene conversion</article-title>
          <source>Trends Genet</source>
          <year>1992</year>
          <volume>8</volume>
          <fpage>416</fpage>
          <lpage>422</lpage>
          <pub-id pub-id-type="pmid">1492367</pub-id>
        </citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papavasiliou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jankovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nussenzweig</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Surrogate or conventional light chains are required for membrane immunoglobulin mu to activate the precursor B cell transition</article-title>
          <source>J Exp Med</source>
          <year>1996</year>
          <volume>184</volume>
          <fpage>2025</fpage>
          <lpage>2030</lpage>
          <pub-id pub-id-type="pmid">8920890</pub-id>
        </citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kubagawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Light-chain gene expression before heavy-chain gene rearrangement in pre&#x2013;B cells transformed by Epstein-Barr virus</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1989</year>
          <volume>86</volume>
          <fpage>2356</fpage>
          <lpage>2360</lpage>
          <pub-id pub-id-type="pmid">2538839</pub-id>
        </citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Freeden-Jeffry</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lucian</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>McNeil</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Burdach</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine</article-title>
          <source>J Exp Med</source>
          <year>1995</year>
          <volume>181</volume>
          <fpage>1519</fpage>
          <lpage>1526</lpage>
          <pub-id pub-id-type="pmid">7699333</pub-id>
        </citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pribyl</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>LeBien</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Interleukin 7 independent development of human B cells</article-title>
          <source>Proc Natl Acad Sci  USA</source>
          <year>1996</year>
          <volume>93</volume>
          <fpage>10348</fpage>
          <lpage>10353</lpage>
          <pub-id pub-id-type="pmid">8816803</pub-id>
        </citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hendriks</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>de Bruijn</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Maas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dingjan</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Karis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grosveld</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre&#x2013;B cell stage</article-title>
          <source>EMBO (Eur Mol Biol Organ) J</source>
          <year>1996</year>
          <volume>15</volume>
          <fpage>4862</fpage>
          <lpage>4872</lpage>
          <pub-id pub-id-type="pmid">8890160</pub-id>
        </citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taub</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hollis</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Hieter</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Korsmeyer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Waldmann</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Leder</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Variable amplification of immunoglobulin &#x3BB; light-chain genes in human populations</article-title>
          <source>Nature</source>
          <year>1983</year>
          <volume>304</volume>
          <fpage>172</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="pmid">6306474</pub-id>
        </citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p>We appreciate the willingness of the patients and their families to participate in research studies. We also  thank J.C. Treadaway and D.K. Mathias for technical assistance, and Drs. J. Rohrer, T. Inukai, and A. Kitanaka for helpful discussions.</p>
      </fn>
      <fn id="FN1">
        <label>1</label>
        <p><italic>Abbreviations used in this paper:</italic> Btk, Bruton's tyrosine kinase; RT-PCR,  reverse transcriptase PCR; SSCP, single strand conformation polymorphism; TdT, terminal deoxyhucleotidyl transferase.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>
